Search research articles
Contact Us
Filters
Showing results (741-750 of 779) with videos related to
Page
of 78
Sort By:
Experimental Neurology
|
January 3, 2009
Normal cortical excitability in Myoclonus-Dystonia--a TMS study
S M A van der Salm, A F van Rootselaar, E M J Foncke, et al.
Toxicology Letters
|
November 13, 2015
Conceptual approaches for treatment of phosgene inhalation-induced lung injury
Wesley W Holmes, Brian M Keyser, Danielle C Paradiso, et al.
ACS Pharmacology & Translational Science
|
August 19, 2022
Characterization of Dual-Acting A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gα<sub>i3</sub> and Gα<sub>oA</sub> Isoprotein Activation
Courtney L Fisher, Lucas B Fallot, Tina C Wan, et al.
European Journal of Neurology
|
July 22, 2014
All in the blink of an eye: new insight into cerebellar and brainstem function in DYT1 and DYT6 dystonia
A Sadnicka, J T Teo, M Kojovic, et al.
Epilepsia
|
November 18, 2022
Short- and long-interval intracortical inhibition in EPM1 is related to genotype
Katri Silvennoinen, Laura Säisänen, Jelena Hyppönen, et al.
Cerebellum (London, England)
|
November 23, 2021
Consensus Paper: Novel Directions and Next Steps of Non-invasive Brain Stimulation of the Cerebellum in Health and Disease
Mario Manto, Georgios P D Argyropoulos, Tommaso Bocci, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
February 3, 2015
Tremor in Charcot-Marie-Tooth disease: No evidence of cerebellar dysfunction
Tabish A Saifee, Isabel Pareés, Panagiotis Kassavetis, et al.
Toxicology Mechanisms and Methods
|
May 17, 2018
Evaluating mice lacking serum carboxylesterase as a behavioral model for nerve agent intoxication
Emily N Dunn, Teresa M Ferrara-Bowens, Mark E Chachich, et al.
Trials
|
June 14, 2017
Choosing the target difference ('effect size') for a randomised controlled trial - DELTA<sup>2</sup> guidance protocol
Jonathan A Cook, Steven A Julious, William Sones, et al.
Trials
|
October 12, 2018
Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA<sup>2</sup> guidance
William Sones, Steven A Julious, Joanne C Rothwell, et al.
Page
of 78
Search research articles
Search
Showing results (741-750 of 779) with videos related to
Sort By:
Page
of 78
Experimental Neurology
|
January 3, 2009
Normal cortical excitability in Myoclonus-Dystonia--a TMS study
S M A van der Salm, A F van Rootselaar, E M J Foncke, et al.
Toxicology Letters
|
November 13, 2015
Conceptual approaches for treatment of phosgene inhalation-induced lung injury
Wesley W Holmes, Brian M Keyser, Danielle C Paradiso, et al.
ACS Pharmacology & Translational Science
|
August 19, 2022
Characterization of Dual-Acting A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gα<sub>i3</sub> and Gα<sub>oA</sub> Isoprotein Activation
Courtney L Fisher, Lucas B Fallot, Tina C Wan, et al.
European Journal of Neurology
|
July 22, 2014
All in the blink of an eye: new insight into cerebellar and brainstem function in DYT1 and DYT6 dystonia
A Sadnicka, J T Teo, M Kojovic, et al.
Epilepsia
|
November 18, 2022
Short- and long-interval intracortical inhibition in EPM1 is related to genotype
Katri Silvennoinen, Laura Säisänen, Jelena Hyppönen, et al.
Cerebellum (London, England)
|
November 23, 2021
Consensus Paper: Novel Directions and Next Steps of Non-invasive Brain Stimulation of the Cerebellum in Health and Disease
Mario Manto, Georgios P D Argyropoulos, Tommaso Bocci, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
February 3, 2015
Tremor in Charcot-Marie-Tooth disease: No evidence of cerebellar dysfunction
Tabish A Saifee, Isabel Pareés, Panagiotis Kassavetis, et al.
Toxicology Mechanisms and Methods
|
May 17, 2018
Evaluating mice lacking serum carboxylesterase as a behavioral model for nerve agent intoxication
Emily N Dunn, Teresa M Ferrara-Bowens, Mark E Chachich, et al.
Trials
|
June 14, 2017
Choosing the target difference ('effect size') for a randomised controlled trial - DELTA<sup>2</sup> guidance protocol
Jonathan A Cook, Steven A Julious, William Sones, et al.
Trials
|
October 12, 2018
Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA<sup>2</sup> guidance
William Sones, Steven A Julious, Joanne C Rothwell, et al.
Page
of 78